UPDATED 20.02.2014 13:22

Organised cervical cancer screening programme in Finland in the invitation year 2011. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 336 municipalities (out of 336).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 178894 1501 0.84 13 0.01 1 0.00 27 0.02 224 0.13 187 0.10 174 0.10 875 0.49
I 167330 8 0.00 - - - - - - - - - - - - 8 0.00
II 10140 358 0.20 - - - - - - 3 0.00 16 0.01 46 0.03 293 0.16
III 1025 1018 0.57 8 0.00 1 0.00 16 0.01 165 0.09 151 0.08 120 0.07 557 0.31
IV 115 115 0.06 5 0.00 - - 11 0.01 54 0.03 20 0.01 8 0.00 17 0.01
V 2 2 0.00 - - - - - - 2 0.00 - - - - - -
Inadequate 9 - - - - - - - - - - - - - - - -
Unknown 273 - - - - - - - - - - - - - - - -
HPV test 6388 142 2.22 - - 1 0.02 1 0.02 10 0.16 10 0.16 16 0.25 104 1.63
Negative1 5874 - - - - - - - - - - - - - - - -
Positive2 514 142 2.22 - - 1 0.02 1 0.02 10 0.16 10 0.16 16 0.25 104 1.63
Total 185282 1643 0.89 13 0.01 2 0.00 28 0.02 234 0.13 197 0.11 190 0.10 979 0.53

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.